Lee Kalowski Sells 3,972 Shares of Homology Medicines (BATS:FIXX) Stock

Homology Medicines, Inc. (BATS:FIXX) CFO Lee Kalowski sold 3,972 shares of the stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total value of $65,776.32. Following the sale, the chief financial officer owned 138,471 shares of the company’s stock, valued at approximately $2,293,079.76. The trade was a 2.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Price Performance

Shares of FIXX stock traded down $0.16 during mid-day trading on Thursday, hitting $12.73. The company’s stock had a trading volume of 978 shares, compared to its average volume of 1,230. Homology Medicines, Inc. has a 52 week low of $12.02 and a 52 week high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.